According to a new report, published by KBV research, The Global Bio Decontamination Market size is expected to reach $393.7 million by 2030, rising at a market growth of 7.3% CAGR during the forecast period.
The Chlorine Dioxide segment is showcasing a CAGR of 7.1% during (2023 - 2030). In humid or warm, moist settings, mold can grow and deteriorate military textiles during storage. Chlorine dioxide can be used to stop this from happening. Chlorine dioxide has a high-water solubility, particularly in cold water, which is one of its most significant properties. As a result, its use for bio-decontamination has increased dramatically.
The Equipment segment is generating the maximum revenue share in the Global Bio Decontamination Market by Product & Service in 2022, thereby achieving a market value of $169.7 million by 2030. This is explained by people choosing automated bio-decontamination technology over manual bio-decontamination techniques more frequently. Additionally, better patient flow in hospitals minimized waste, increased portability, and minimal footprint, which helped the market's revenue growth. There is minimal to no water used during automatic disinfection. Additionally, there is less chance of garbage overflow, which could even harm the ecology. Automated equipment runs for the time required to adequately clean the environment. The segment's revenue growth is anticipated to be fuelled by these factors.
The Room Decontamination segment has shown a high growth rate of 8.9% during (2023 - 2030). All biological contaminants, either airborne or found on surfaces, must be fully absent from clean rooms to be considered truly clean. Clean room decontamination is crucial if there has been a breach in cleanliness. Choosing a reputable and validated room bio-decontamination service will be less likely that the product or being is compromised.
The Pharma & Medical Device Companies segment acquired the highest revenue share in the Global Bio Decontamination Market by End User in 2022, thereby achieving a market value of $173.6 million by 2030. The pharmaceutical & medical device manufacturing companies segment registered the maximum revenue share in the bio decontamination market in 2022. Due to stringent good manufacturing production criteria, the pharmaceutical & medical device production industries extensively use bio-decontamination goods and services. By regularly monitoring medication manufacturers' adherence to its Current Good Manufacturing Practice (CGMP) regulations, the U.S. Food and Medication Administration (FDA) safeguards the quality of drug products. The minimum conditions for the procedures, settings, and controls used in creating, processing, and packaging a drug product are outlined in the CGMP standards for pharmaceuticals.
The North America region dominated the Global Bio Decontamination Market by Region in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $146.7 million by 2030. The Europe market is showcasing a CAGR of 7.1% during (2023 - 2030). Additionally, The Asia Pacific market would witness a CAGR of 8.3% during (2023 - 2030).
Full Report: https://www.kbvresearch.com/bio-decontamination-market/
The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the globe with country wise analysis in each discussed region. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of STERIS PLC, Ecolab, Inc., TOMI Environmental Solutions, Inc., JCE Biotechnology SAS, Fedegari Autoclavi S.p.A., Zhejiang TAILIN Bioengineering Co., Ltd., Howorth Air Technology Limited, Solidfog Technologies SPRL, ClorDiSys Solutions, Inc., and Amira Srl.
By Agent Type
By Product & Service
By Type
By End User
By Geography
Companies Profiled
Unique Offerings 
